292 related articles for article (PubMed ID: 20889901)
1. Stenotrophomonas maltophilia in cystic fibrosis: serologic response and effect on lung disease.
Waters V; Yau Y; Prasad S; Lu A; Atenafu E; Crandall I; Tom S; Tullis E; Ratjen F
Am J Respir Crit Care Med; 2011 Mar; 183(5):635-40. PubMed ID: 20889901
[TBL] [Abstract][Full Text] [Related]
2. Chronic Stenotrophomonas maltophilia infection and exacerbation outcomes in cystic fibrosis.
Waters V; Atenafu EG; Salazar JG; Lu A; Yau Y; Matukas L; Tullis E; Ratjen F
J Cyst Fibros; 2012 Jan; 11(1):8-13. PubMed ID: 21849265
[TBL] [Abstract][Full Text] [Related]
3. Chronic pulmonary infection with Stenotrophomonas maltophilia and lung function in patients with cystic fibrosis.
Dalbøge CS; Hansen CR; Pressler T; Høiby N; Johansen HK
J Cyst Fibros; 2011 Sep; 10(5):318-25. PubMed ID: 21463972
[TBL] [Abstract][Full Text] [Related]
4. Chronic Stenotrophomonas maltophilia infection and mortality or lung transplantation in cystic fibrosis patients.
Waters V; Atenafu EG; Lu A; Yau Y; Tullis E; Ratjen F
J Cyst Fibros; 2013 Sep; 12(5):482-6. PubMed ID: 23294530
[TBL] [Abstract][Full Text] [Related]
5. Development of a quantitative immunofluorescence assay for detection of Stenotrophomonas maltophilia antibodies in patients with cystic fibrosis.
Gonçalves Vidigal P; Schmidt D; Stehling F; Mellies U; Steinmann E; Buer J; Rath PM; Steinmann J
J Cyst Fibros; 2013 Dec; 12(6):651-4. PubMed ID: 23706828
[TBL] [Abstract][Full Text] [Related]
6. Detecting Stenotrophomonas maltophilia does not reduce survival of patients with cystic fibrosis.
Goss CH; Otto K; Aitken ML; Rubenfeld GD
Am J Respir Crit Care Med; 2002 Aug; 166(3):356-61. PubMed ID: 12153970
[TBL] [Abstract][Full Text] [Related]
7. Factors influencing the acquisition of Stenotrophomonas maltophilia infection in cystic fibrosis patients.
Stanojevic S; Ratjen F; Stephens D; Lu A; Yau Y; Tullis E; Waters V
J Cyst Fibros; 2013 Dec; 12(6):575-83. PubMed ID: 23757360
[TBL] [Abstract][Full Text] [Related]
8. Stenotrophomonas maltophilia infection in hematopoietic SCT recipients: high mortality due to pulmonary hemorrhage.
Tada K; Kurosawa S; Hiramoto N; Okinaka K; Ueno N; Asakura Y; Kim SW; Yamashita T; Mori SI; Heike Y; Maeshima AM; Tanosaki R; Tobinai K; Fukuda T
Bone Marrow Transplant; 2013 Jan; 48(1):74-9. PubMed ID: 22635245
[TBL] [Abstract][Full Text] [Related]
9. Stenotrophomonas maltophilia: to be or not to be a cystic fibrosis pathogen.
Hansen CR
Curr Opin Pulm Med; 2012 Nov; 18(6):628-31. PubMed ID: 22990659
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal study of Stenotrophomonas maltophilia antibody levels and outcomes in cystic fibrosis patients.
Wettlaufer J; Klingel M; Yau Y; Stanojevic S; Tullis E; Ratjen F; Waters V
J Cyst Fibros; 2017 Jan; 16(1):58-63. PubMed ID: 27346471
[TBL] [Abstract][Full Text] [Related]
11. Association between glucose intolerance and bacterial colonisation in an adult population with cystic fibrosis, emergence of Stenotrophomonas maltophilia.
Lehoux Dubois C; Boudreau V; Tremblay F; Lavoie A; Berthiaume Y; Rabasa-Lhoret R; Coriati A
J Cyst Fibros; 2017 May; 16(3):418-424. PubMed ID: 28284526
[TBL] [Abstract][Full Text] [Related]
12. Use of random amplified polymorphic DNA PCR to examine epidemiology of Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans from patients with cystic fibrosis.
Krzewinski JW; Nguyen CD; Foster JM; Burns JL
J Clin Microbiol; 2001 Oct; 39(10):3597-602. PubMed ID: 11574579
[TBL] [Abstract][Full Text] [Related]
13. Pan-Resistant Achromobacter xylosoxidans and Stenotrophomonas maltophilia Infection in Cystic Fibrosis Does Not Reduce Survival After Lung Transplantation.
Lobo LJ; Tulu Z; Aris RM; Noone PG
Transplantation; 2015 Oct; 99(10):2196-202. PubMed ID: 25856407
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for emergence of Stenotrophomonas maltophilia in cystic fibrosis.
Talmaciu I; Varlotta L; Mortensen J; Schidlow DV
Pediatr Pulmonol; 2000 Jul; 30(1):10-5. PubMed ID: 10862157
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial susceptibility profile of molecular typed cystic fibrosis Stenotrophomonas maltophilia isolates and differences with noncystic fibrosis isolates.
Cantón R; Valdezate S; Vindel A; Sánchez Del Saz B; Maíz L; Baquero F
Pediatr Pulmonol; 2003 Feb; 35(2):99-107. PubMed ID: 12526070
[TBL] [Abstract][Full Text] [Related]
16. Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis.
Goss CH; Mayer-Hamblett N; Aitken ML; Rubenfeld GD; Ramsey BW
Thorax; 2004 Nov; 59(11):955-9. PubMed ID: 15516471
[TBL] [Abstract][Full Text] [Related]
17. Characterization of small-colony-variant Stenotrophomonas maltophilia isolated from the sputum specimens of five patients with cystic fibrosis.
Anderson SW; Stapp JR; Burns JL; Qin X
J Clin Microbiol; 2007 Feb; 45(2):529-35. PubMed ID: 17135443
[TBL] [Abstract][Full Text] [Related]
18. Adaptation of Stenotrophomonas maltophilia in cystic fibrosis: molecular diversity, mutation frequency and antibiotic resistance.
Vidigal PG; Dittmer S; Steinmann E; Buer J; Rath PM; Steinmann J
Int J Med Microbiol; 2014 Jul; 304(5-6):613-9. PubMed ID: 24836944
[TBL] [Abstract][Full Text] [Related]
19. Molecular Characterization of Stenotrophomonas maltophilia isolates from cystic fibrosis patients and the hospital environment.
Marzuillo C; De Giusti M; Tufi D; Giordano A; Del Cimmuto A; Quattrucci S; Mancini C; Villari P
Infect Control Hosp Epidemiol; 2009 Aug; 30(8):753-8. PubMed ID: 19583515
[TBL] [Abstract][Full Text] [Related]
20. Denitrification by cystic fibrosis pathogens - Stenotrophomonas maltophilia is dormant in sputum.
Kolpen M; Kragh KN; Bjarnsholt T; Line L; Hansen CR; Dalbøge CS; Hansen N; Kühl M; Høiby N; Jensen PØ
Int J Med Microbiol; 2015 Jan; 305(1):1-10. PubMed ID: 25441256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]